#LCSM Chat topic 11/17– FB Live Q&A with NCI on Immunotherapy and Clinical Trials


For Lung Cancer Awareness Month, the National Cancer Institute (NCI) is once again partnering with #LCSM Chat for a special event.

During the first half of our November 17 tweetchat, which starts at the usual 8 PM Eastern time (5 PM Pacific), the NCI’s Dr. Shakun Malik (head of thoracic oncology therapeutics) and Janet Freeman-Daily (lung cancer patient/activist and founding member of #LCSM Chat) will have a 30-minute Facebook Live question and answer session on the topic of “Immunotherapy for Lung Cancer: New Research and Clinical Trials.”  The Facebook Live event will be visible on the National Cancer Institute’s Facebook page.

Concurrent with the Facebook Live event, #LCSM Chat will conduct their regularly scheduled Twitter chat 11/17 starting at 8 PM.  For the first 30 minutes of the chat, topics will parallel the Facebook Live discussion.  After the Facebook Live event concludes, the second half of the tweetchat will focus on resources for accessing clinical trials.  Deana Hendrickson (@LungCancerFaces) will moderate the first half of the chat, and Janet Freeman-Daily (@JFreemanDaily) will join her in moderating the second half of the chat.

Please feel free to ask questions for Dr. Malik or Ms. Freeman-Daily on the NCI Facebook page or during the #LCSM Twitter chat.

First half chat topics will mirror those in the Facebook Live event:

  • T1: What is the role immunotherapies play in lung cancer research and treatment?
  • T2: What is new in the Lung-MAP clinical trial?
  • T3: What is new in the ALCHEMIST clinical trial?
  • T4: What is the role of genetic testing in screening and qualifying for lung cancer clinical trials?
  • T5: What resources are available to help patients and caregivers investigate clinical trials?

Second half chat topics will continue discussing clinical trials:

  • T6: What tools and services are available to help patients and caregivers investigate lung cancer clinical trials?
  • T7: What considerations affect your decision to join a clinical trial?

Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here. A link to the chat transcript and a Storify summary will be available within a few days on our Schedules and Transcripts page.

We look forward to chatting with you about lung cancer immunotherapy and clinical trials on November 17.

#LCSM Chat topic 11/3: #LCAM—Pick Your Passion

It’s November, and that means LUNG CANCER AWARENESS MONTH is here! The registered Twitter hashtag for Lung Cancer Awareness Month this year (and hopefully all future years) is #LCAM.

If you want to get involved in spreading awareness and generating support for lung cancer patients, caregivers, and research, you’re in luck.  Our #LCSM Chat on November 3, 2016, at 8 pm ET (5 pm Pacific) will discuss how YOU can get involved in LCAM.

In addition to the LCAM materials and resources available from lung cancer advocacy organizations (see list at the end of this post), we will be highlighting a new collaborative #LCAM effort. The website lcam.org was created specifically for LCAM by the International Association for the Study of Lung Cancer (IASLC), in partnership with several lung cancer advocacy groups. The logo at the top of this blog post is the LCAM logo created for LCAM.org. The site is unbranded and aims to offer hope to those affected by lung cancer. This year the site focuses on patient stories with supporting factoids, a calendar of LCAM events (starting with the Nov 1 LCAM Press Conference in Washington, DC), and options for purchasing LCAM logo merchandise (the proceeds of which support lung cancer research).

Patients and caregivers can contribute to LCAM in a number of ways:

  • Watch Facebook, Twitter and media for posts about lung cancer, and share them on social media
  • Share your lung cancer story on lcam.org and other sites (see below)
  • Attend lung cancer events
  • Look for ways to expand your advocacy
  • Donate to lung cancer organizations that do work important to you

Our stories have a greater impact when they have a clear message. The majority of this chat will focus on hints for telling your lung cancer story in a way that attracts readers and media attention. To guide our exploration of lung cancer storytelling, we will have two special guests:

  • Mark Story (@markstory_) is a strategic communications executive and cancer communicator with more than 20 years of experience. His mother died of lung cancer.  While his day job is at the NCI, he is in no way representing the organization nor its views in this chat.
  • Jennifer Stauss (@jenniferjstauss) has more than 18 years in public relations, crisis communications and social media strategy. She used these skills to highlight her Mom’s journey through lung cancer through their joint politically incorrect social media campaign called “WTF? (Where’s the Funding) for Lung Cancer.”

Our guests will suggest ways to (1) tell your story to generate the greatest impact, (2) pitch your story to local and national media outlets, and (3) leverage your story in different types of advocacy.

Be aware that sharing your story means going public with health information (good overview in this thoughtful post by Marie Ennis O’Connor, AKA @JBBC). You really do need to think about privacy implications before writing.

Our moderator @JFreemanDaily (Janet Freeman-Daily) will guide our conversation using the following questions:

  • T1: What materials and resources are available for #LCAM advocates?
  • T2: What are some tips for sharing my #lungcancer story effectively for #LCAM?
  • T3: How can I get media interested in #lungcancer stories?
  • T4: How might I share my #lungcancer story in other forms of #lungcancer advocacy?

Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here. A link to the chat transcript and a Storify summary will be available within a few days on our Schedules and Transcripts page.

We look forward to chatting with you about #LCAM storytelling on November 3!



You can find resources and information at lung cancer advocacy organization websites in this list of Lung Cancer Action Network (LungCAN) members.

The websites listed below have specific Lung Cancer Awareness Month pages.

Organization: International Association for the Study of Lung Cancer
LCAM resource: share your story on lcam.org (new collaborative LCAM website)
hashtag: #LCAM and #LCSM

Organization: American Lung Association (ALA)
LCAM resource: share your story at www.LUNGFORCE.org
hashtag: #LungForce

Organization: The Bonnie J. Addario Lung Cancer Foundation
LCAM resource: National Lung Cancer Awareness Month
hashtag: #beatlungcancer

Organization: Free to Breathe
LCAM resource: post a video
hashtag #fliptobreathe

Organization: Lung Cancer Alliance
LCAM resource: Five easy ways to make a difference
hashtag: #ShareHope

Organization: Lung Cancer Foundation of America (LCFA)
LCAM resource: “Little Things” videos
hashtag: #littlethingsLCFA

Organization: Lung Cancer Initiative of North Carolina
LCAM resource: attend an event
hashtag: #LCAM

Organization: Lung Cancer Social Media
LCAM resource: tweetable LC facts
hashtag: #LCAM and #LCSM

Organization: LUNGevity Foundation
LCAM resource: share your story on social media
hashtag: #changelc

#LCSM Chat Topic Thu 10/20 (8pm ET): Social media and doctors–should we go there?

by Brendon Stiles, MD

doctors-and-social-mediaI (@BrendonStilesMD) am pleased to be moderating the October 20, 2016 #LCSM Chat (8pm Eastern, 5pm Pacific).   The topic of the chat will be “Social media and doctors:  should we go there?”

I am giving a talk on a similar topic in April of 2017 at the Annual Meeting of the American Association for Thoracic Surgery (AATS).  I am proud of the fact that thoracic surgery’s most prestigious academic association has recognized the importance of doctor-patient interactions on social media. In preparation for that timely talk, I would love to get input (from patients, caregivers, advocates, physicians, and from anyone interested in cancer) on cancer communication within the realm of social media. I hope to convey to my colleagues the potential that social media platforms such as Twitter have for breaking down long standing barriers to information dissemination and to shared decision making.  Along with that task, I hope to assure my medical peers that they can engage in social media without a loss of privacy or of professionalism and to instruct them how best to do so.  With those goals in mind, I plan to discuss the following topics:

  • T1:  What are the benefits to cancer physicians of participating in social media?
  • T2:  What do patients, caregivers, advocates expect from cancer physicians on social media?
  • T3:  Have you ever felt that physicans or patients have crossed boundaries on social media?  If yes, how so?
  • T4:  How can physicians best share personal information, stories, and opinions yet still be “professional”?

I am relying on this #LCSM Chat to serve as the base of my talk in April.  I hope you will join us for this important topic, which I hope to use to drive increased physician participation in #LCSM and other topics. Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here.


%d bloggers like this: